Skip to main content

Advertisement

SpringerLink
Log in

Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma

  • Letter to the Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bedke J, Gauler T, Grünwald V et al (2017) Systemic therapy in metastatic renal cell carcinoma. World J Urol 35(2):179–188. https://doi.org/10.1007/s00345-016-1868-5

    Article  PubMed  CAS  Google Scholar 

  2. De Wolf K, Rottey S, Vermaelen K et al (2017) Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial. Radiat Oncol 12(1):157. https://doi.org/10.1186/s13014-017-0893-x

    Article  PubMed  PubMed Central  Google Scholar 

  3. Pollom EL, Deng L, Pai RK et al (2015) Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body RadiationTherapy. Int J Radiat Oncol Biol Phys 92(3):568–576. https://doi.org/10.1016/j.ijrobp.2015.02.016

    Article  PubMed  PubMed Central  Google Scholar 

  4. Hurwitz HI, Dowlati A, Saini S et al (2009) Phase I trial of pazopanib in patients with advanced cancer. Clin Cancer Res 15(12):4220–4227. https://doi.org/10.1158/1078-0432.CCR-08-2740.E

    Article  PubMed  CAS  Google Scholar 

  5. Barney BM, Markovic SN, Laack NN, Miller RC et al (2013) Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys 87(1):73–80. https://doi.org/10.1016/j.ijrobp.2013.05.012

    Article  PubMed  CAS  Google Scholar 

  6. Patient Preference Study of Pazopanib Versus Sunitinib in Advanced or Metastatic Kidney Cancer (PISCES). (2013). Network sitehttp://clinicaltrials.gov/ct2/show/NCT01064310?term=pazopanib+pisces&rank=1

  7. Miller JA, Balagamwala EH, Angelov L et al (2016) Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma. J Neurosurg Spine 25(6):766–774. https://doi.org/10.3171/2016.4.SPINE16229

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Kayseri Education and Research Hospital, Sanayi District, Ataturk Boulevard, Hastane Street, No:78, 38010, Kayseri, Turkey

    Yasemin Benderli Cihan

Authors
  1. Yasemin Benderli Cihan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasemin Benderli Cihan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cihan, Y.B. Effectiveness of pazopanib and SBRT in metastatic renal cell carcinoma. World J Urol 36, 1797–1798 (2018). https://doi.org/10.1007/s00345-018-2323-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-018-2323-6

Search

Navigation